CGEN
Compugen Ltd.
Company Overview
| Mkt Cap | $159.91M | Price | $1.77 |
| Volume | 322.79K | Change | +7.27% |
| P/E Ratio | -11.2 | Open | $1.66 |
| Revenue | $27.9M | Prev Close | $1.65 |
| Net Income | $-14.2M | 52W Range | $1.13 - $2.66 |
| Div Yield | N/A | Target | $6.25 |
| Overall | 58 | Value | -- |
| Quality | 50 | Technical | 66 |
No chart data available
Stock Overview
Updated DailyCompugen Ltd. (CGEN) is a leading Healthcare company in the Biotechnology industry, currently trading at $1.77 with a market capitalization of $159.91 million. The stock is trading in the middle of its 52-week range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows CGEN with a volume of 323K shares. The stock opened up 0.61% from yesterday's close of $1.65. Current analyst estimates project earnings of $-0.34 per share for this year, with next year targeting $-0.26.
CGEN demonstrates weak technical indicators based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including SGEN, EVGN, PSTI, TEVA, BTX.
Key investment considerations for CGEN include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 253.1%. The stock shows neutral valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 03:52 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CGEN | $1.77 | +7.3% | 322.79K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |